(Q44160398)

30 November 2017

title

Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone (English)

1 reference

30 November 2017

0 references

E L J Hoogervorst

1

1 reference

30 November 2017

C H Polman

series ordinal

2

1 reference

30 November 2017

F Barkhof

series ordinal

3

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Multiple Sclerosis Journal

30 November 2017

published in

1 reference

30 November 2017

volume

8

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

415-419

1 reference

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Apparent Cerebral Atrophy in Patients on Treatment with Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Cranial Computed Tomography (CCT) Findings in Children Treated with ACTH and Dexamethasone: First Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Optimizing the association between disability and biological markers in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS838OA

10.1191/1352458502MS838OA

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference